公开(公告)号：US20240131054A1

公开(公告)日：2024-04-25

申请号：US18382179

申请日：2023-10-19

Applicant: Graceful Caring Hands, Inc.

Inventor： Olukunle Jacob Adebiyi

IPC: A61K33/00 ,  A61K9/00 ,  A61K9/08 ,  A61K31/09 ,  A61K31/495 ,  A61P11/02 ,  A61P11/04

CPC classification number: A61K33/00 ,  A61K9/0043 ,  A61K9/0056 ,  A61K9/0095 ,  A61K9/08 ,  A61K31/09 ,  A61K31/495 ,  A61P11/02 ,  A61P11/04

Abstract: A dosing regimen for administering a composition to a patient for treatment of congestion or irritation includes administering a first dose of the composition to the patient. The composition is formulated as an aqueous solution including between about 0.125 to about 1 milliequivalents of sodium bicarbonate per milliliter of the aqueous solution. The first dose includes between about 0.25 to about 1 milliliter of the composition. The dosing regimen also includes administering a second dose of the composition to the patient after administration of the first dose. The second dose includes between about 0.25 to about 1 milliliter of the composition.

公开(公告)号：US20240075035A1

公开(公告)日：2024-03-07

申请号：US18271716

申请日：2022-01-12

Applicant: APNIMED, INC. (DELAWARE)

Inventor： Ronald FARKAS ,  Luigi TARANTO-MONTEMURRO ,  Lawrence G MILLER

IPC: A61K31/513 ,  A61K31/138 ,  A61K31/216 ,  A61P11/04 ,  A61P25/20

CPC classification number: A61K31/513 ,  A61K31/138 ,  A61K31/216 ,  A61P11/04 ,  A61P25/20

Abstract: Pharmaceutical compositions comprising Lemborexant or a pharmaceutically acceptable salt thereof and a norepinephrine reuptake inhibitor (NRI) and methods of treating Sleep Apnea comprising administering Lemborexant or a pharmaceutically acceptable salt thereof and an NRI are described herein. In some embodiments, the NRI is atomoxetine or a pharmaceutically acceptable salt thereof. In some embodiments, the pharmaceutical compositions further comprise a muscarinic receptor antagonist (MRA). In some embodiments, the methods of treating Sleep Apnea further comprise administering an MRA. In some embodiments, the MRA is oxybutynin or a pharmaceutically acceptable salt thereof.

公开(公告)号：US11911478B2

公开(公告)日：2024-02-27

申请号：US17114104

申请日：2020-12-07

Applicant: Johnson & Johnson Consumer Inc.

Inventor： Gerard P. McNally ,  Anurag Pandey ,  Vipul Dave

IPC: A61K47/38 ,  A61P11/14 ,  A61P11/04 ,  A61K9/08 ,  A61K47/10 ,  A61K47/34 ,  A61P11/00 ,  A61K31/09 ,  A61K31/137 ,  A61K31/167 ,  A61K31/192 ,  A61K31/485 ,  A61K47/26 ,  A61K47/32

CPC classification number: A61K47/38 ,  A61K9/08 ,  A61K31/09 ,  A61K31/137 ,  A61K31/167 ,  A61K31/192 ,  A61K31/485 ,  A61K47/10 ,  A61K47/26 ,  A61K47/32 ,  A61K47/34 ,  A61P11/00 ,  A61P11/04 ,  A61P11/14

Abstract: Compositions useful in the treatment of cough and cold symptoms, including but not limited to, cough, nasal congestion and sore throat, are disclosed.